Corvitol 100

Corvitol 100: Beta blocker for the cardiovascular system

Corvitol 100 is a pharmaceutical drug belonging to the group of beta1-blockers. The main active ingredient in Corvitol 100 is metoprolol. This drug is manufactured by Berlin-Chemie AG and Menarini Group in Germany and is a cardioselective beta-blocker.

Corvitol 100 is presented in the form of tablets containing 100 mg of metoprolol. It is used to treat various cardiovascular diseases and heart rhythm disorders. The drug has the following synonyms: betalka, betalka zo, vasocardin, vasocardin retard, corvitol, Corvitol 50, Lopresor, Metohexal, Metard, Metocard retard, Metolol, metoprolol of OF, metoprolol of 200 retard, metoprolol-Raithopharmic -Teva, Serdol and Spes.

The main indications for use of Corvitol 100 include:

1. Arterial hypertension of moderate and moderate severity. The drug can be used as monotherapy or in combination with other antihypertensive drugs.
2. Coronary heart disease (CHD).
3. Hyperkinetic cardiac syndrome.
4. Heart rhythm disturbances, including sinus tachycardia, ventricular and supraventricular arrhythmia, paroxysmal tachycardia, supraventricular tachycardia, extrasystole, atrial flutter and fibrillation, atrial tachycardia.
5. Hypertrophic cardiomyopathy and mitral valve prolapse.
6. Prevention and treatment of myocardial infarction.
7. Migraine prevention.
8. Complex therapy of thyrotoxicosis.
9. Treatment of akathisia caused by neuroleptics.

However, there are a number of contraindications to the use of Corvitol 100. It is not recommended in the following cases:

1. Hypersensitivity to metoprolol or other components of the drug.
2. AV block II and III degrees, sinoatrial block.
3. Acute or chronic heart failure in the decompensation stage.
4. Sick sinus syndrome, severe sinus bradycardia (heart rate less than 60 beats per minute).
5. Cardiogenic shock.
   6. Isolated arterial hypotension (systolic blood pressure below 90 mm Hg).
6. Bronchial asthma and obstructive airway diseases.
7. Acute cardiac disease requiring treatment with inotropic drugs.
8. Pheochromocytoma not controlled by antihypertensive therapy.
9. Severe peripheral circulatory disorders (including reactive vascular diseases).
10. Children and adolescents under 18 years of age (for this dosage).

Before taking Corvitol 100, you should consult your doctor so that he can evaluate the indications and contraindications for the use of the drug in your particular case. The doctor will also determine the required dosage and regimen for taking the medication.

It is important to follow your doctor's instructions and not exceed the recommended dose of Corvitol 100. You should not change the dosage yourself or stop taking the drug without consulting your doctor, as this may adversely affect your health.

I hope this information is useful to you. However, it is always recommended to consult a medical specialist or pharmacist for more accurate and individualized information about medications and their use.